These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 681749)

  • 21. Nonselective destruction of murine neoplastic cells by syngeneic tumoricidal macrophages.
    Fogler WE; Fidler IJ
    Cancer Res; 1985 Jan; 45(1):14-8. PubMed ID: 3855280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ontogeny of 'macrophage' function. IV. Newborn mouse macrophages strongly suppress tumour cell growth and readily acquire cytolytic activity in comparison with adult macrophages.
    Ido M; Uno K; Inaba K; Aotsuka Y; Muramatsu S
    Immunology; 1984 Jun; 52(2):307-17. PubMed ID: 6735438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages.
    Hori K; Mihich E; Ehrke MJ
    Cancer Res; 1989 May; 49(10):2606-14. PubMed ID: 2496917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage activation for tumor cytotoxicity: analysis of cellular lipid and fatty acid content during lymphokine activation.
    Schlager SI; Meltzer MS
    J Reticuloendothel Soc; 1981 Mar; 29(3):227-40. PubMed ID: 7218233
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of the effects of endotoxin on macrophage tumor cell killing.
    Weinberg JB; Chapman HA; Hibbs JB
    J Immunol; 1978 Jul; 121(1):72-80. PubMed ID: 27559
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of allogenic Dalton's lymphoma cells on the activation of murine peritoneal macrophages to tumoricidal state by cisplatin and lipopolysaccharide (LPS).
    Singh SM; Singh RK; Sodhi A
    Neoplasma; 1992; 39(3):151-5. PubMed ID: 1528319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo modulation of macrophage tumoricidal activity: enhanced tumor cell killing by peritoneal macrophages from mice given injections of sodium periodate.
    Weinberg JB
    J Natl Cancer Inst; 1981 Mar; 66(3):529-33. PubMed ID: 6259399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activation of tumoricidal properties of rat peritoneal macrophages using lipopolysaccharide.
    Kalafut F; Kusenda J; Klobusická M; Novotná L
    Neoplasma; 1990; 37(4):405-14. PubMed ID: 2234202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor cytotoxicity of rat alveolar macrophages activated in vitro by endotoxin.
    Sone S; Fidler IJ
    J Reticuloendothel Soc; 1980 Mar; 27(3):269-79. PubMed ID: 7365733
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. II. Down-regulation of macrophage-mediated cytotoxicity by tumor-derived granulocyte-macrophage colony-stimulating factor.
    Sotomayor EM; Fu YX; Lopez-Cepero M; Herbert L; Jimenez JJ; Albarracin C; Lopez DM
    J Immunol; 1991 Oct; 147(8):2816-23. PubMed ID: 1918995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxicity of human macrophages for tumor cells: enhancement by bacterial lipopolysaccharides (LPS).
    Cameron DJ; Churchill WH
    J Immunol; 1980 Feb; 124(2):708-12. PubMed ID: 7356710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage activation for tumor cytotoxicity: genetic variation in macrophage tumoricidal capacity among mouse strains.
    Boraschi D; Meltzer MS
    Cell Immunol; 1979 Jun; 45(1):188-94. PubMed ID: 378423
    [No Abstract]   [Full Text] [Related]  

  • 33. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of recombinant human tumor necrosis factor on the induction of murine macrophage tumoricidal activity.
    Hori K; Ehrke MJ; Mace K; Maccubbin D; Doyle MJ; Otsuka Y; Mihich E
    Cancer Res; 1987 Jun; 47(11):2793-8. PubMed ID: 2882835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness.
    Boraschi D; Meltzer MS
    J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563
    [No Abstract]   [Full Text] [Related]  

  • 36. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide-nonresponsive murine macrophages.
    Dong Z; Qi X; Xie K; Fidler IJ
    J Immunol; 1993 Sep; 151(5):2717-24. PubMed ID: 7689614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
    Pace JL; Russell SW
    J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage activation for tumor cytotoxicity: analysis of intermediary reactions.
    Meltzer MS; Ruco LP; Boraschi D; Nacy CA
    J Reticuloendothel Soc; 1979 Oct; 26(4):403-15. PubMed ID: 390144
    [No Abstract]   [Full Text] [Related]  

  • 39. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
    Schafer R; Nacy CA; Eisenstein TK
    J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation.
    Meltzer MS
    J Immunol; 1981 Jul; 127(1):179-83. PubMed ID: 7240741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.